Skip to Content

  • Search

View Additional Section Content

RTOG - 0815 - A Phase III Prospective Randomized Trial of Dose Escalated Radiotherapy with or without Short-term Androgen Deprivation Therapy for Patient with Intermediate Risk Prostate Cancer.


RATIONALE:  Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells. Androgen-deprivation therapy may lessen the amount of androgens made by the body. It is not yet known whether radiation therapy is more effective with or without androgen-deprivation therapy in treating patients with prostate cancer.

PURPOSE:  This randomized phase III trial is studying radiation therapy to see how well it works compared with radiation therapy given together with androgen-deprivation therapy in treating patients with prostate cancer. 


IRB Protocol Number
NCT00936390, RTOG - 0815

Clinical Trial Categories

  • Prostate Cancer
The Rosenfeld Cancer Center at 215-481-2402

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details